Details of issuance or disposal
Public offering of the 8th, 9th and 10th series of unsecured bonds (with a pari passu clause limited to bonds)
8th series: ¥20 billion; 9th series: ¥10 billion; 10th series: ¥20 billion; total: ¥50 billion
Not applicable (this is an issuance of bonds and no dilution of shares is disclosed)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Public offering of the 8th, 9th and 10th series of unsecured bonds (with a pari passu clause limited to bonds) |
| Issue price and disposal price | ¥100 per ¥100 face value of each bond |
| Total issue value | 8th series: ¥20 billion; 9th series: ¥10 billion; 10th series: ¥20 billion; total: ¥50 billion |
| Amount of funds to be raised | Total amount paid in: ¥50 billion; estimated net proceeds: Not disclosed |
| Specific use of funds | Details Working capital related to research and development of key development products / Amount Not disclosed / Scheduled timing of expenditures Not disclosed, Details Investment in in-licensed products / Amount Not disclosed / Scheduled timing of expenditures Not disclosed, Details Funds for repayment of short-term borrowings / Amount Not disclosed / Scheduled timing of expenditures Not disclosed |
| Payment date | 10 June 2026 |
| Intended allottee | No specific prospective allottee, as this is a public offering: Not disclosed |
| Dilution Rate | Not applicable (this is an issuance of bonds and no dilution of shares is disclosed) |
| Underwriter / lead underwriter | Nomura Securities Co., Ltd., Goldman Sachs Japan Co., Ltd., SMBC Nikko Securities Inc. |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To diversify funding sources for investment in in-licensed products and other purposes aimed at further business growth. The funds raised are expected to be allocated to working capital related to research and development of key development products, investment in in-licensed products, and repayment of short-term borrowings.